Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Gains from Sales and Divestitures (2018 - 2020)

United Therapeutics' Gains from Sales and Divestitures history spans 3 years, with the latest figure at $104818.0 for Q1 2020.

  • On a quarterly basis, Gains from Sales and Divestitures rose 127.73% to $104818.0 in Q1 2020 year-over-year; TTM through Mar 2020 was $104818.0, a 127.73% increase, with the full-year FY2019 number at $74324.0, up 290.13% from a year prior.
  • Gains from Sales and Divestitures hit $104818.0 in Q1 2020 for United Therapeutics, up from $74324.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for UTHR hit a ceiling of $104818.0 in Q1 2020 and a floor of $17820.0 in Q2 2018.
  • Historically, Gains from Sales and Divestitures has averaged $51762.5 across 3 years, with a median of $55192.0 in 2019.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 290.13% in 2019 and later soared 127.73% in 2020.
  • Tracing UTHR's Gains from Sales and Divestitures over 3 years: stood at $19051.0 in 2018, then skyrocketed by 290.13% to $74324.0 in 2019, then skyrocketed by 41.03% to $104818.0 in 2020.
  • Business Quant data shows Gains from Sales and Divestitures for UTHR at $104818.0 in Q1 2020, $74324.0 in Q4 2019, and $69761.0 in Q3 2019.